Chemistry: molecular biology and microbiology – Treatment of micro-organisms or enzymes with electrical or...
Reexamination Certificate
2006-10-31
2006-10-31
Saucier, Sandra E. (Department: 1651)
Chemistry: molecular biology and microbiology
Treatment of micro-organisms or enzymes with electrical or...
C435S173400, C435S173700, C424S577000
Reexamination Certificate
active
07129070
ABSTRACT:
A method is presented for killing a first population of cells within a mixture of viable cells by providing the mixture of viable cells, contacting the cells with a label, illuminating a portion of the mixture, capturing an image of multiple cells in the illuminated portion of the mixture, determining at least two dimensional coordinates of one or more cells of the first population of cells using the first captured image, and applying a lethal dose of energy to said dimensional coordinates of the one or more cells at a first focal plane.
REFERENCES:
patent: 3674926 (1972-07-01), Dewey et al.
patent: 4284897 (1981-08-01), Sawamura et al.
patent: 4395397 (1983-07-01), Shapiro
patent: 4532402 (1985-07-01), Overbeck
patent: 4624915 (1986-11-01), Schindler et al.
patent: 4629687 (1986-12-01), Schindler et al.
patent: 4803992 (1989-02-01), Lemelson
patent: 5013660 (1991-05-01), Kasuya et al.
patent: 5035693 (1991-07-01), Kratzer et al.
patent: 5053693 (1991-10-01), Bohnert et al.
patent: 5089384 (1992-02-01), Hale
patent: 5103660 (1992-04-01), Johnson
patent: 5158889 (1992-10-01), Hirako et al.
patent: 5188633 (1993-02-01), Kratzer et al.
patent: 5202230 (1993-04-01), Kamentsky
patent: 5272081 (1993-12-01), Weinreb et al.
patent: 5296963 (1994-03-01), Murakami et al.
patent: 5298963 (1994-03-01), Moriya et al.
patent: 5381224 (1995-01-01), Dixon et al.
patent: 5422720 (1995-06-01), Berndt
patent: 5523543 (1996-06-01), Hunter, Jr. et al.
patent: 5646411 (1997-07-01), Kain et al.
patent: 5672880 (1997-09-01), Kain
patent: 5690846 (1997-11-01), Okada et al.
patent: 5719391 (1998-02-01), Kain
patent: 5785703 (1998-07-01), Goodman et al.
patent: 5795755 (1998-08-01), Lemelson
patent: 5874266 (1999-02-01), Palsson
patent: 5890846 (1999-04-01), Clark et al.
patent: 5932872 (1999-08-01), Price
patent: 6005256 (1999-12-01), McGlynn et al.
patent: 6007814 (1999-12-01), Scheinberg
patent: 6040139 (2000-03-01), Bova
patent: 6122396 (2000-09-01), King et al.
patent: 6143535 (2000-11-01), Palsson
patent: 6148096 (2000-11-01), Pressman et al.
patent: 6315772 (2001-11-01), Marchitto et al.
patent: 6381224 (2002-04-01), Lane et al.
patent: 6424863 (2002-07-01), Flock et al.
patent: 6514722 (2003-02-01), Palsson et al.
patent: 6642018 (2003-11-01), Koller et al.
patent: 6753161 (2004-06-01), Koller et al.
patent: 2002/0076744 (2002-06-01), Koller et al.
patent: 2003/0219892 (2003-11-01), Palsson et al.
patent: 0 662 512 (1995-07-01), None
patent: 63-259465 (1987-04-01), None
patent: 2054486 (1996-02-01), None
patent: WO 89/01630 (1989-02-01), None
patent: WO 97/11156 (1997-03-01), None
patent: WO 98/42356 (1998-10-01), None
patent: WO 98/52016 (1998-11-01), None
Merriam-Webster Online Dictionary definition of “image”. From www.m-w.com, accessed Sep. 14, 2005. 2 pages.
Andersen et al., “Failure of immunologic purging in mantle cell lymphoma assessed by polymerase chain reaction detection in minimal residual disease,”Blood, 90: 4212-4221 (1997).
Brittberg et al., “Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation,” N.E.J.Med., 331: 889-895 (1994).
Brockstein et al., “Tumor cell contamination of bone marrow harvest products: Clinical consequences in a cohort of advanced-stage breast cancer patients undergoing high-dose chemotherapy,”J. Hematotherapy, 5: 617-624 (1996).
Brugger et al., “Mobilization of Tumor Cells and Hematopoietic Progenitor Cells Into Peripheral Blood of Patients with Solid Tumors,”Blood, 83: 636-640 (1994).
Campana et al., “Detection of Minimal Residual Disease in Acute Leukemia: Methodologic Advances and Clinical Significance,”Blood85: 1416-1434 (1995).
Chute et al., “Analysis of the steady-state dynamics organelle motion in cultured neurities,”Clin Exp Pharmco Physiol, 22: 360 (1995).
Clarke et al., “A recombinantbcl-xsadenovirus selectively induces apoptosis in cancer cells but not in normal bone marrow cells,”Proc. Natl. Acad. Sci. USA, 92: 11024-11028 (1995).
Cossman et al., “Reed-Sternberg cell genome expression supports a B-cell lineage,”Blood, 94: 411-416 (1999).
Deisseroth et al., “Genetic marking shows that Ph+cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML,”Blood, 83: 3068-3076 (1994).
Dooley et al., “A Novel, Inexpensive Technique for the Removal of Breast Cancer Cells from Mobilized Peripheral Blood Stem Cell Products,”Blood, 88: 252a, Abstract 995, 438-II (1996).
Fields et al., “Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation,”J. Clin. Oncol., 14: 1868-1876 (1996).
Gazitt et al., “Purified CD34+Lin Thy+Stem Cells Do Not Contain Clonal Myeloma Cells,”Blood, 86: 381-389 (1995).
Gee, Adrian P., “Part 5: Autologous Bone Marrow Purging,”Bone Marrow Processing and Purging,248-328 (1991).
Grate et al., Laser-mediated, site-specific inactivation of RNA transcripts,PNAS, 96:6131-6136 (1999).
Greer et al., “A Clonogenic Culture Method for the Identification of Breast Cancer Cells in Marrow Aspirates of Patients Receiving High-Dose Chemotherapy,” Blood, 88: 252a, Abstract 996, 439 II (1996).
Gribben et al., “Antibody-mediated Purging; Bone Marrow Transplantation,”Boston-Blackwell Scientific Publications, 149-163 (1994).
Gribben et al., “Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma,”N.E.J. Med., 325:1525-1533 (1991).
Gulati et al., “Rationale for Purging in Autologous Stem Cell Transplantation,”Journal of Hemtatotherapy, 2: 467-471 (1993).
Guo et al., “Laser-mediated gene transfer in rice,”Physiologia Plantarum, 93: 19-24 (1995).
Hanaia et al., “A Novel Automated Method of Scanning Cytometry and Laser-Induced Necrosis applied to Tumor Cell Purging,”Blood94: 638A-639A (1999).
Huang et al., “Symmetry of initial cell divisions among primitive hematopoietic progenitors is independent of ontogenic age and regulatory molecules,”Blood, 94: 2595-2604 (1999).
Jasuja et al., “Chemotactic responses ofEscherichia colito small jumps of photoreleased L-aspartate,”Biophysical Journal, 76: 1706-1719 (1999).
Jay, D. G., “Selective destruction of protein function by chromophore-assisted laser inactivation,”PNAS, 85: 5454-5458 (1988).
Koller et al., “Tissue Culture Surface Characteristics Influence the Expansion of Human Bone Marrow Cells,”Biomaterials, 19: 1963-1972 (1988).
Langer et al., “The challenges ahead,”Sci. Am., 280: 86-89 (1999).
Lazarus et al., “DoesIn VitroBone Marrow Purging Improve the Outcome after Autologous Bone Marrow Transplantation?,”Journal of Hematotherapy, 2: 457-466 (1993).
Lydaki et al., “Merocyanine 540 mediated photolysis of normal bone marrow, committed hemopoietic progenitors and neoplastic cells. Implications for bone marrow purging,”Leukemia Research, 21: 641-650.
Lydaki et al., “Merocyanine 540 mediated photoirradiation of leukemic cells, In vitro inference on cell survival,”Journal of Photochemistry and Photobiology B: Biology, 32: 27-32 (1996).
Mapara et al., “Monitoring of tumor cell purging after highly efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients: Comparison of immunocytochemical tumor cell staining and reverse transcriptase-polymerase chain reaction,”Blood, 89: 337-344 (1997).
Miller et al., “Rapid Killing of Single Neurons by Irradiation of Intracellular Injected Dye,”Science, 206: 702-704 (1979).
Oh et al., “Phototoxicity of the Fluorescent Membrance Dyes PKH2 and PKH26 on the Human Hematopoietic KG1a Progenitor Cell Line,”Cytometr
Barnhart Lora E
Cyntellect, Inc.
Knobbe Martens Olson & Bear LLP
Saucier Sandra E.
LandOfFree
Targeted system for removing tumor cells from cell populations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Targeted system for removing tumor cells from cell populations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Targeted system for removing tumor cells from cell populations will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3620658